Background. Prognosis of PD is variable. Most studies show higher mortality rates in PD patients compared to the general population. Clinical and epidemiologic factors predicting mortality are poorly understood. Methods. Clinical and epidemiologic features including patient history and physical, functional, and cognitive scores were collected from a hospital-based cohort of PD patients using standardized protocols and clinical scales. Data on comorbidities and mortality were collected on follow-up. Results. During a mean follow-up of 4.71 years (range 1–10), 43 (20.9%) of the 206 patients died. Those who died had higher mean age at disease onset than those still alive at the last follow-up (67.7 years versus 56.3 years; p<0.01). In the univ...
Objective Few studies have followed Parkinson’s disease (PD) patients from the time of diagnosis to ...
Identification of factors predicting and driving mortality in PD is important for patient informatio...
AbstractBackgroundThe best data on prognosis comes from population-based incident cohorts but few su...
OBJECTIVE: To determine the life expectancy of patients with Parkinson disease (PD) in the United St...
Objective: To evaluate whether the survival of patients with Parkinson disease (PD) is shorter than ...
BACKGROUND: Earlier research showed that Parkinson's disease is related to increased overall mortali...
Mortality rate, life expectancy, survival, and the impact of comorbidities on them in people with Pa...
Background: Survival in patients with Parkinson's disease is reduced as compared to the general popu...
In a set of a population-based study, long-term survival of 59 prevalent PD patients was compared wi...
Objective To examine mortality and associated risk factors, including possible effects of mild cogni...
Background: previous studies on mortality of Parkinson's disease (PD) enrolled a relatively small nu...
The increasing age of the general population and of patients suffering from Parkinson's disease sugg...
Copyright © 2014 John C. Morgan et al.This is an open access article distributed under theCreative C...
Parkinson’s disease (PD) is associated with increased mortality despite many advances in treatment. ...
Introduction: Disease interactions can alter functional decline near the end of life (EOL). Parkinso...
Objective Few studies have followed Parkinson’s disease (PD) patients from the time of diagnosis to ...
Identification of factors predicting and driving mortality in PD is important for patient informatio...
AbstractBackgroundThe best data on prognosis comes from population-based incident cohorts but few su...
OBJECTIVE: To determine the life expectancy of patients with Parkinson disease (PD) in the United St...
Objective: To evaluate whether the survival of patients with Parkinson disease (PD) is shorter than ...
BACKGROUND: Earlier research showed that Parkinson's disease is related to increased overall mortali...
Mortality rate, life expectancy, survival, and the impact of comorbidities on them in people with Pa...
Background: Survival in patients with Parkinson's disease is reduced as compared to the general popu...
In a set of a population-based study, long-term survival of 59 prevalent PD patients was compared wi...
Objective To examine mortality and associated risk factors, including possible effects of mild cogni...
Background: previous studies on mortality of Parkinson's disease (PD) enrolled a relatively small nu...
The increasing age of the general population and of patients suffering from Parkinson's disease sugg...
Copyright © 2014 John C. Morgan et al.This is an open access article distributed under theCreative C...
Parkinson’s disease (PD) is associated with increased mortality despite many advances in treatment. ...
Introduction: Disease interactions can alter functional decline near the end of life (EOL). Parkinso...
Objective Few studies have followed Parkinson’s disease (PD) patients from the time of diagnosis to ...
Identification of factors predicting and driving mortality in PD is important for patient informatio...
AbstractBackgroundThe best data on prognosis comes from population-based incident cohorts but few su...